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Background. Through 2 international traveler-focused surveillance networks (GeoSentinel and TropNet), we iden-
tiﬁed and investigated a large outbreak of acute muscular sarcocystosis (AMS), a rarely reported zoonosis caused by a
protozoan parasite of the genus Sarcocystis, associated with travel to Tioman Island, Malaysia, during 2011–2012.
Methods. Clinicians reporting patients with suspected AMS to GeoSentinel submitted demographic, clinical, itin-
erary, and exposure data. We deﬁned a probable case as travel to Tioman Island after 1 March 2011, eosinophilia (>5%),
clinical or laboratory-supported myositis, and negative trichinellosis serology. Case conﬁrmation required histologic
observation of sarcocysts or isolation of Sarcocystis species DNA from muscle biopsy.
Results. Sixty-eight patients met the case deﬁnition (62 probable and 6 conﬁrmed). All but 2 resided in Europe; all
were tourists and traveled mostly during the summer months. The most frequent symptoms reported were myalgia
(100%), fatigue (91%), fever (82%), headache (59%), and arthralgia (29%); onset clustered during 2 distinct periods:
“early” during the second and “late” during the sixth week after departure from the island. Blood eosinophilia and
elevated serum creatinine phosphokinase (CPK) levels were observed beginning during the ﬁfth week after departure.
Sarcocystis nesbitti DNA was recovered from 1 muscle biopsy.
Conclusions. Clinicians evaluating travelers returning ill fromMalaysia with myalgia, with or without fever, should
consider AMS, noting the apparent biphasic aspect of the disease, the later onset of elevated CPK and eosinophilia, and
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the possibility for relapses. The exact source of infection among travelers to Tioman Island remains unclear but needs to be determined
to prevent future illnesses.
Keywords. infectious disease outbreak; sarcocystosis; parasitic disease; Malaysia; travel.
On 25 October 2011, GeoSentinel, the surveillance program of
the International Society of Travel Medicine (ISTM) and the US
Centers for Disease Control and Prevention (CDC) [1], was no-
tiﬁed of a cluster of ill German patients recently returned from
Tioman Island, off the eastern coast of peninsular Malaysia
(Figure 1) [2, 3]. These patients had an unusual clinical
presentation: All of them reported fever and signiﬁcant muscle
pain, had blood eosinophilia and elevated serum creatinine
phosphokinase (CPK) levels, and tested seronegative for trichi-
nellosis and toxoplasmosis. A muscle biopsy from one of
these patients was diagnostic for acute muscular sarcocystosis
(AMS), a rarely reported zoonotic infection. The GeoSentinel
Figure 1. Tioman Island, Malaysia, and locations visited by 68 case patients with acute muscular sarcocystosis, 2011–2012. Marker color represents the
frequency of visitation to each village or attraction for the 61 case patients with these data available; each patient may have visited multiple locations. Other
locations visited but not mapped include “south of Tekek” (n = 4), “between Ayer Batang and Salang” (n = 3), “between Ayer Batang and Genting” (n = 1),
“Tekek to Juara” (n = 1), “northwest of island” (n = 3), and a snorkeling trip circumnavigating the island by boat with multiple stops (n = 1). Tioman Island is
not drawn to scale relative to the mainland.
1402 • CID 2014:59 (15 November) • Esposito et al
(available at: http://www.istm.org/geosentinel and http://www.
istm.org/eurotravnet) and TropNet (available at: http://www.
tropnet.net) networks contacted their members and alerted rel-
evant public health authorities to conduct additional case ﬁnd-
ing. Within days of the network alerts, additional patients were
identiﬁed, prompting further investigation [2, 4].
Human muscular sarcocystosis is caused by an intracellular
protozoan parasite of the genus Sarcocystis (available at:
http://www.cdc.gov/dpdx/sarcocystosis/index.html). First de-
scribed in 1843, approximately 130 species of Sarcocystis have
been identiﬁed from a variety of wild and domestic mammals,
birds, and reptiles [5]. These organisms have an obligatory
2-host life cycle, alternating between predator and prey (the de-
ﬁnitive–intermediate hosts). Humans are the deﬁnitive host for
Sarcocystis hominis and Sarcocystis suihominis, acquired by eat-
ing undercooked sarcocyst-containing beef or pork, respective-
ly. Deﬁnitive host infection is limited to the intestine and may
cause acute gastroenteritis, although most infections are proba-
bly asymptomatic [6]. Humans can also become the accidental
dead-end intermediate host for an unknown number of other
Sarcocystis species, presumably acquired by ingesting sporo-
cyst-containing food or water contaminated with feces from in-
fected carnivores. In the intermediate host, generations of
reproduction occur in the vasculature, ultimately leading to
the formation of characteristic cysts (sarcocysts) within myo-
cytes of skeletal, cardiac, and, infrequently, smooth muscle.
Until recently, <100 cases of human muscular sarcocystosis
were reported in the literature, particularly from Malaysia [7–
9]. The majority of these cases were diagnosed incidentally in
asymptomatic persons or in patients whose symptoms were
not clearly related to their Sarcocystis infection. At most, 10 of
these cases had symptomatic AMS [10–13]; an additional recent
report describes an outbreak involving 89 patients with AMS
acquired on Pangkor Island, off the west coast of peninsular
Malaysia [14]. Effective treatment for this disease has not
been determined.
The principal objectives of this investigation were to describe
the clinical, laboratory, and epidemiologic characteristics of this
outbreak of AMS. We also sought to identify possible sources of
infection among the ill travelers, and to alert clinicians to con-
sider AMS when evaluating ill returned travelers.
METHODS
Epidemiologic Investigation
GeoSentinel is a global provider-based, traveler-focused sentinel
surveillance network established collaboratively by ISTM and
the CDC [1]. The 57 GeoSentinel sites in 24 countries consist
of travel and tropical medicine clinics that actively monitor trav-
el-related morbidity. TropNet is a European travel and tropical
medicine research and surveillance network [15]. Together,
these networks encompass >110 travel and tropical medicine
sites and >225 participating afﬁliated sites worldwide.
After the ﬁrst patients were reported, members of these net-
works were notiﬁed of the outbreak through e-mail alerts and
other informal channels. In addition, the networks communi-
cated to the larger infectious diseases community through
ProMED Mail postings [16–19] and published outbreak alerts
[2, 4]. Relevant global public health authorities were also noti-
ﬁed. All were encouraged to report patients suspected of having
AMS to GeoSentinel. Clinicians were asked to complete 2 struc-
tured questionnaires: one for demographic and clinical data and
one for travel and exposures. They were also asked to document
the date of onset for a list of symptoms that were based on our
experience with the ﬁrst reported patients, as well as a literature
review. This outbreak investigation was determined to be public
health response, and thus institutional review board review was
not required. All patients gave informed consent.
We report only those patients meeting an intentionally spe-
ciﬁc outbreak case deﬁnition of probable or conﬁrmed AMS. A
probable case required travel to Tioman Island after 1 March
2011, with myositis, eosinophilia >500 cells/µL, and negative
trichinellosis serology. Myositis required at least 1 of the follow-
ing: a complaint of muscle pain and a CPK level >200 IU/L;
muscle tenderness documented on physical examination; or
histologic evidence of myositis in a muscle biopsy. Case conﬁr-
mation required histologic observation of intramuscular cysts
compatible with sarcocysts or the isolation of Sarcocystis species
DNA from a muscle biopsy.
Laboratory Analysis
Diagnostic testing was at the discretion of the clinician but could
include complete blood counts and differentials, serum biochem-
ical testing, electrocardiography, echocardiography, imaging
studies, and electromyography. Some patients were tested for spe-
ciﬁc diseases such as malaria, intestinal parasites, toxocariasis,
ﬁlariasis, and dengue, chikungunya, and Epstein-Barr virus infec-
tion. Serum samples were requested, and testing at the CDC
Parasitic Diseases Reference Laboratory for trichinellosis, toxo-
plasmosis, and strongyloidiasis was performed on available sam-
ples not previously tested as part of the initial clinical evaluation.
Sera were also used by the CDC for developing a serological assay
for human sarcocystosis using both whole digested merozoites
and recombinant surface peptides of Sarcocystis neurona.
At the discretion of the clinician, some patients underwent
muscle biopsy. All biopsies were examined histologically by a
pathologist at the institution where collected. When possible,
tissue blocks, frozen tissue, and extracted DNA cryoprecipitate
were sent to the CDC Infectious Diseases Pathology Branch for
additional examination, including histopathology, polymerase
chain reaction (PCR) detection, and DNA sequencing analysis
of Sarcocystis species 18S ribosomal RNA (rRNA) amplicons.
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For histopathologic examination, 3-µm sections were cut from
formalin-ﬁxed, parafﬁn-embedded muscle biopsy specimens
and stained with hematoxylin and eosin. For electron microsco-
py (EM), a parafﬁn section was embedded in Epon-Araldite
epoxy resin, removed from the slide and glued to a blank EM
block, sectioned and stained, and examined in an FEI Tecnai
Spirit microscope. PCR ampliﬁcation was performed with a
primer pair designed to amplify a fragment of approximately
800 base pairs from the 18S rRNA gene of different species of
Sarcocystis [20]. Amplicons were sequenced by using BigDye
version 3.1 chemistry (Applied Biosystems), and sequence
data were analyzed as previously described [21].
Statistical Analysis
Descriptive statistics were estimated using SAS software, version
9.2 (SAS Institute).
RESULTS
Epidemiologic Characteristics of Case Patients
Demographic and Travel Characteristics
From October 2011 through April 2013, 99 ill persons who
returned home after travel to Tioman Island were reported to
GeoSentinel as having suspected AMS. Overall, 68 (69%)
patients met the case deﬁnition and were included in the anal-
ysis; 62 were probable and 6 were conﬁrmed cases. The median
age of these patients was 34 years (range, 4–72 years); 39 (57%)
were female. Of the 31 who did not meet the case deﬁnition, 24
did not satisfy criteria for myositis and 5 did not have eosino-
philia, trichinellosis testing, or both.
More than three-quarters of the case patients resided in ei-
ther Germany (43%) or France (34%). Fourteen (21%) lived
elsewhere in Europe (6 in the Netherlands, 3 in Switzerland, 2
each in Belgium and Spain, and 1 in Italy); the 2 non-Europeans
resided in Canada and Singapore. Most traveled to Tioman
Island during the European summer months (Figure 2); all
were tourists. The median stay was 5 days (range, 3–16 days),
with 49 (72%) of the travelers staying <7 days.
Exposures
Complete travel and exposure data were submitted from 61
(90%) case patients. Most lodging, eating, and recreational
activities were concentrated on the northwest coast of Tioman
Island; no single village or attraction was visited by >40 (68%,
data missing for 2) case patients (Figure 1). All travelers report-
ed eating at restaurants and lodging at resorts, hotels, huts, or
bungalows; no single eating or lodging establishment was visit-
ed by >22 (36%, Table 1). All case patients visited a beach, and
Figure 2. Date of departure from Tioman Island, Malaysia, by week, of 68 travelers with probable and conﬁrmed acute muscular sarcocystosis, 2011–
2012. The date of departure from Tioman Island reﬂects the last possible point of exposure of the traveler to the Sarcocystis species parasite. The earliest
departure date was 1 May 2011, and the latest was 5 September 2012.
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all but 1 (98%) reported swimming in the ocean. All but 1 pa-
tient reported consuming drinks with ice, and most ate fresh
produce that might have been washed with unsafe water and/
or brushed their teeth using tap water. Cats were frequently ob-
served in tourist areas. Reptiles (including snakes and lizards)
and monkeys were infrequently contacted.
Clinical and Laboratory Findings
Case patients ﬁrst became ill a median of 11 days (range, 0–40
days) after departing from Tioman Island. The most frequent
symptoms reported among the 68 case patients were myalgia
(100%), fatigue (91%), fever (82%), headache (59%), and ar-
thralgia (29%); other symptoms were less frequently reported
(Figure 3). Patients were ﬁrst evaluated by the reporting clini-
cian at different points during the course of their illness;
physical examination data were collected only on that ﬁrst
visit, which was a median of 44 days (range, 12–79 days) after
departing from the island. Twenty-nine of 55 (53%) case pa-
tients were febrile (temperature ≥38°C); 19 of these had a tem-
perature ≥39°C. Muscle tenderness was present among 47 of 64
(73%) and was described as moderate or severe in 32 (68%).
Thirty-eight of 64 (88%) had tenderness involving their extrem-
ities; 1 reported tenderness of the masseter muscle of the face
and another of the tongue. Skin rash, lung ﬁndings, and lymph-
adenopathy were each found in ≤3 patients. One patient report-
ed subcutaneous nodules on the chin and neck that resolved
prior to presentation, and another had muscle fasciculations in-
volving all 4 extremities. One patient had a thrombosis of the
left sigmoidal and transverse sinuses followed by pulmonary
emboli; no clotting abnormality was found, and a sarcocysto-
sis-related vasculitis could not be ruled out. One patient was
pregnant at the time of infection; she experienced no complica-
tions. No patient was known to have an underlying medical
condition (such as immunosuppression) that would have
been expected to have affected the infection. At least 7 case
patients (10%) were hospitalized; none required intensive care.
Onset of the 5 most frequent symptoms appeared to cluster
during 2 distinct periods: early during the second and late dur-
ing the sixth week after departure (Figure 4A). No other symp-
tom showed this pattern. To account for persons presenting at
different times during the course of their illness, we also restrict-
ed the analysis to those who sought care after the fourth post-
departure week; the biphasic symptom-onset pattern persisted.
For 25 (37%) patients, the illness was described as phasic, inter-
mittent, or waxing–waning in character, with periods of symp-
toms separated by a period of relative improvement.
Although few absolute eosinophil counts or serum CPK levels
were performed during the ﬁrst 4 postdeparture weeks, elevations
in both were noted most frequently during the late period, after
the fourth week postdeparture (Figure 4B and 4C). Of 10 case
patients with a mildly elevated CPK-myocardial band (MB) frac-
tion, 8 had a normal electrocardiogram (ECG), echocardiogram,
or troponin, and none were thought to have cardiac pathology.
One patient with a normal CPK-MB fraction, troponin, and
ECG on presentation had an echocardiogram showing mild dila-
tation of right ventricular outﬂow and was thought clinically to
have developed mild myocarditis. Eighteen (26%) case patients
had positive Toxoplasma immunoglobulin G, but all those tested
were immunoglobulinM negative (6 unknown). Strongyloides se-
rology was positive in 4 (6%, 2 unknown). Attempts to develop
and validate a serologic assay for human Sarcocystis species infec-
tion were unsuccessful due to inconsistent reactivity of sera from
patients with conﬁrmed sarcocystosis and cross-reactivity of sera
from patients with known toxoplasmosis.
Patients were treated with a range of antiparasitic agents, in-
cluding albendazole, as well as oral steroids. Some clinicians
Table 1. Exposures Reported by 61 of 68 Case Patients With
Acute Muscular Sarcocystosis and With Data Available, Tioman
Island, Malaysia, 2011–2012
Travel Exposures (n = 61) Frequency %
Transportation to island
By ferry only 42 69
By air only 8 13
Both ferry and air 11 18
Activity exposures
Ate at restaurantsa 61 100
Stayed at resort, hotel, hut, or bungalowa 61 100
Visited a beach 61 100
Swam in the ocean 60 98
Swam in freshwater 12 20
Snorkeled 53 87
Scuba dived 18 30
Food/water exposuresb
Drank beverages with ice 60 98
Ate fresh vegetables or fruits 47 77
Brushed teeth with tap water 40 66
Animal exposures
Cats seen in restaurant kitchens, dining rooms,
beachesc
37 61
Touched or fed a cat or kitten 43 72
Touched or fed a monkey 8 14
Touched or fed a lizard 8 14
Touched or fed a dog or puppy 2 4
Touched or fed a snake or rodent 0 0
Missing values: Swam in fresh water (1), cats seen in restaurant kitchens,
dining rooms, beaches (1), touched or fed a monkey (2), touched or fed a
lizard (4), touched or fed a dog or puppy (4).
a No single eating or lodging establishment was visited by >22 (36%) of
travelers.
b A single patient lacked any of these potential exposures.
c Unsolicited information spontaneously reported in the questionnaire narrative;
similar mention was not made for any other animals, including reptiles and
monkeys.
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reported symptom improvement on oral steroids, although we
could not determine whether improvement was due to the med-
ication or the natural course of the illness. The patient with mild
myocarditis was treated with oral steroids and improved, al-
though causality could not be established.
Histopathology and Species Identiﬁcation
Fifteen patients had a muscle biopsy performed a median of 60
days postdeparture (range, 39–92 days). All tissue samples were
examined histologically by a pathologist where collected. The
CDC received tissue from a total of 14 (93%) biopsied patients,
as tissue blocks, extracted DNA cryoprecipitate, frozen tissue,
and/or prepared slides. Photographs of representative histopa-
thology were received from 8 patients, 1 from the patient
from whom tissue was not available. In all samples and photo-
graphs examined, histopathology showed inﬂammation that
was predominantly perivascular within the endomysium and
perimysium with a wide range of severity, from rare foci of pre-
dominantly lymphohistiocytic inﬂammation to more frequent
foci of mixed inﬂammation (Figure 5A). Sarcocysts were ob-
served histologically in the muscle of only 6 patients (40%), de-
spite intensive searches including examination of >60 sections
from a single muscle biopsy sample in which a lone sarcocyst
was observed by a pathologist at the point where collected.
When present, intramyocytic sarcocysts were characterized by
single, large (up to 100 µm in width and several hundred
micrometers in length), thin-walled, septated cysts containing
innumerable, crescent-shaped bradyzoites that were approxi-
mately 4 × 8 µm (Figure 5B); no inﬂammation was observed
immediately adjacent to any sarcocyst. By EM, large cysts
were found embedded in skeletal muscle; they contained
numerous, approximately 3.5 µm bradyzoites (Figure 5C).
The cyst wall demonstrated short, undulating type 1 protrusions
(Figure 5D) [5].
Ten patients had PCR testing for Sarcocystis species DNA; 1
biopsy sample, also with sarcocysts visible on histopathology,
was positive. The sequencing analysis of the ampliﬁed fragment
showed 100% similaritywith the 18S rRNAgene from Sarcocystis
nesbitti (GenBank accession number HF544323).
DISCUSSION
We report 68 travelers with AMS acquired while vacationing on
Tioman Island, Malaysia. The spectrum of AMS in humans is
broad: from asymptomatic, which may characterize most infect-
ed patients [7–9], to severe and relapsing illness lasting years
[11]. Comparable with other reports, the majority of the Tio-
man Island patients experienced muscle pain, fatigue, fever,
and headache. In contrast, we did not ﬁnd cough, rash, lymph-
adenopathy, swelling, facial tenderness, subcutaneous nodules,
Figure 3. Symptoms among 68 patients with acute muscular sarcocystosis, Tioman Island, Malaysia, 2011–2012. Shown are the proportions of patients
experiencing each symptom at any time during the course of their illness. Symptoms reported in <5% of the case patients are not shown and include throat
pain* (3%), loss of appetite (3%), and stiff neck* (1%). *Unsolicited symptom spontaneously reported in the questionnaire narrative.
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or cardiac abnormalities to be prominent, although patients
were not examined at standardized intervals [10–14].
Onset of symptoms occurred in 2 distinct phases: early (be-
ginning within the second week postdeparture) and late (begin-
ning within the sixth week postdeparture). As others have
reported, more than one-third of our patients experienced wax-
ing and waning of symptoms [11, 14]. We found that the late
phase corresponded with a rise in the serum CPK level and
blood eosinophil count, possibly reﬂecting the onset of an im-
mune-mediated myositis. All 15 muscle biopsies showed histo-
logic evidence of varying degrees of diffuse multifocal myositis;
all were done on or after the 39th day after departure from the
island, and none had evidence of inﬂammation immediately ad-
jacent to any observed sarcocyst. As few CPK determinations
and no biopsies were done within 5 weeks of departure from
the island, earlier development of myositis cannot be ruled
out. The lack of clinical suspicion, reﬂected by the paucity of
serum CPK and biopsy data in the early weeks, however, sug-
gests that this is unlikely.
The phasic nature of AMS in humans reported here is well
characterized in animals with experimentally induced interme-
diate-host infections [5]. Signs and symptoms of disease in
animals reﬂect the stages of development and the migratory tra-
jectories of the parasite as it passes from the intestine via the
vascular endothelium to its ﬁnal destination within the myo-
cyte. The exact time course, however, depends on the speciﬁc
species of infecting Sarcocystis and the speciﬁc host species
that is infected [5]. Given the patterns observed among the Tio-
man Island patients, we hypothesize that disease in humans
parallels that seen in animals. More work is needed to charac-
terize the pathophysiology of disease in humans infected by Sar-
cocystis species as the intermediate host.
Despite the presence of swimming beaches and lodging
across the island, the ill travelers concentrated most of their ac-
tivities on the northwest portion; however, no obvious source of
infection could be identiﬁed through epidemiologic analyses, al-
though nearly all case patients reported potential exposure to
untreated water. Cats were ubiquitous and were frequently ob-
served in tourist areas, with nearly three-quarters of the case pa-
tients reporting having either touched or fed a cat. Although
long-tailed macaques [22] and numerous reptile species, includ-
ing water monitors and a variety of snakes [23], inhabit Tioman
Island, few patients reported contacts. Interestingly, an environ-
mental evaluation on the island conducted by the Malaysia
Figure 4. Timing of speciﬁc elements of acute muscular sarcocystosis.
A, Onset of the 5 most frequently reported symptoms of acute muscular
sarcocystosis relative to the number of weeks since departing from Tioman
Island; onset clustered during the second (early) and the sixth (late) post-
departure weeks. More than 1 onset date for at least 1 of these symptoms
was reported by 15 patients (myalgia [n = 10], fever [n = 7], headache
[n = 2], fatigue [n = 1]; none for arthralgia). For 25 (37%) patients, the illness
was described as phasic, intermittent, or waxing–waning in character,
with periods of symptoms separated by a period of relative improvement.
B and C, All blood absolute eosinophil counts and serum creatinine phos-
phokinase (CPK) levels, respectively, for all patients relative to the number
Figure 4 continued. of weeks since departing Tioman Island. Each case
patient may have had >1 of each laboratory determination. One absolute
eosinophil count of 6200 cells/µL and 1 CPK level of 3900 U/L, each from a
different patient, is not included in B and C, respectively. *Based on the
case deﬁnition, >500 cells/µL is considered elevated. †Based on the case
deﬁnition, >200 U/L is considered elevated.
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Ministry of Health (MMoH) in response to this outbreak isolat-
ed Escherichia coli from almost all, and parasites from several,
sampled water sources, although no Sarcocystis species were re-
covered [24]. In addition, no Sarcocystis species sporocysts were
observed in the animal feces that were sampled, including from
cats. Although the MMoH isolated Toxoplasma gondii from
sampled cats, none of the case patients identiﬁed during this
outbreak had evidence of acute toxoplasmosis, as might be ex-
pected if cats were the source of this outbreak. Notably, the
MMoH did not sample any local rodent, bird, or reptile species
during their survey of the island, and their investigation was
limited in scope and conducted during the monsoon season,
at a time when no infections among travelers were being report-
ed [22–25]. Travelers to Tioman Island should be advised to
practice proper precautions, including avoiding contact with
animals, eating and drinking safe food and water, and washing
hands frequently.
We identiﬁed S. nesbitti from the formalin-ﬁxed muscle tis-
sue of a patient with acute myositis and multiple sarcocysts ob-
served on microscopic examination of histologic sections. This
ﬁnding corroborates recent data showing that S. nesbitti was re-
covered from the muscle of 2 of 89 acutely ill patients [14].
Sarcocystis nesbitti has been considered to be a potential cause
of human infections because it infects Southeast Asian species
of nonhuman primates, including the long-tailed macaque, and
because it resembles morphologically sarcocysts seen in humans
[26–28].Although the natural life cycle of this organism has not
yet been deﬁnitively determined, evidence is mounting that
S. nesbitti has a snake species as its natural deﬁnitive host
[29–31]. An understanding of the natural life cycle of this zoo-
notic parasite would aid the development of preventive mea-
sures and messaging.
AMS among travelers is largely a clinical diagnosis that re-
quires an understanding of symptoms and symptom progres-
sion and the geographic risk distribution of the disease. Early
diagnosis is made difﬁcult by the nonspeciﬁc nature of the
early phase of the disease and the absence of a simple and ac-
curate diagnostic test, such as serology. Diagnosis in the later
phase may be easier because relatively few infectious diseases
are characterized by clinical myositis and eosinophilia, the
most notable exception being trichinellosis. In addition, the bi-
phasic nature of the illness may offer a hint to the clinician. Cur-
rently, deﬁnitive diagnosis requires histologic observation of
sarcocysts in or ampliﬁcation of Sarcocystis species DNA by
PCR from a muscle biopsy sample. However, we found that sar-
cocysts are likely distributed diffusely and difﬁcult to ﬁnd.
Figure 5. Histopathology and electron microscopy. A, Skeletal muscle (SM) with inﬂammation (arrows) adjacent to a small vessel (v). Inﬂammation com-
posed of lymphocytes and macrophages with small numbers of plasma cells, eosinophils, and rarely neutrophils. Original magniﬁcation ×400, hematoxylin
and eosin staining. B, SM with intramyocytic sarcocyst. Note the absence of inﬂammation surrounding the sarcocyst-containing myocyte. Original mag-
niﬁcation 400×, hematoxylin and eosin staining. C, Portion of a cyst within SM, containing abundant bradyzoites (arrow). D, Higher magniﬁcation of the cyst
wall, showing short protrusions (arrow) and a fairly thin granular layer (GL). Bars = 2 µm (C) and 500 nm (D). Abbreviations: GL, granular layer; SM, skeletal
muscle; v, small vessel.
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Although there is currently no treatment regimen that has been
shown to be effective, anti-inﬂammatory agents may be helpful
in the management of pain. The value of speciﬁc antiparasitic
agents is an area for further exploration.
These data have several limitations. At the outset of this in-
vestigation, AMS in humans was not well characterized and rel-
evant data may have gone unrecorded. Data were gathered
retrospectively and at different stages of disease, potentially af-
fecting the accuracy of patient recall. Many clinicians from a va-
riety of countries and practice settings participated in data
collection, which may have introduced variability in data con-
sistency. Finally, our methods likely identiﬁed more severely af-
fected patients. Our data may not reﬂect disease among all
patients infected with S. nesbitti, some of whom may have
been asymptomatic.
Our data largely corroborate previous descriptions of human
sarcocystosis and offer important new details on this emerging
disease. Foremost among these is the suggestion of a 2-phase
clinical presentation, commencing about 2 and 6 weeks after in-
fection. Unfortunately, the outbreak investigation did not lend
itself to determining what proportion of those infected remain
asymptomatic, assessing the various therapeutic measures, or
determining the typical duration of illness. Clinicians who see
posttravel illness should add AMS to their differential diagnosis
of the ill patient returning from Malaysia with myalgia, with or
without fever, noting the apparent biphasic aspect of the dis-
ease, the later onset of elevated CPK and eosinophilia, and
the possibility for relapses. Although only 1 biopsy was positive
by PCR, our work and the work of others suggest S. nesbitti as a
cause of human AMS. Further studies should focus on conﬁrm-
ing the natural life cycle of this organism to develop preventive
recommendations, following patients along the full course of
their illnesses, and studying treatment options. To prevent fu-
ture illnesses among travelers to Tioman Island, the exact source
of the outbreak needs to be determined and transmission
interrupted.
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